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Background: To investigate the effects of microvascular compromise on the expression of oxidative proteins in the
optic nerve head.
Methods: Endothelin-1 (0.1 μg/day) was delivered to the perineural region of the anterior optic nerve by
osmotically driven minipumps for two, four, and eight weeks in ten rabbits, respectively. As a control, a balanced
salt solution was delivered for two and eight weeks in five rabbits, respectively. Expression of oxyproteins in the
cornea, vitreous, retina, and optic nerve head for each time period was determined using the OxyBlot protein
oxidation detection kit. Retina was stained with H&E and TUNEL for histological examination.
Results: There was a significant increase in the expression of oxyproteins in the optic nerve head after two weeks
of endothelin-1 administration (p < 0.001, Mann Whitney U test). In contrast, there was no expression of oxyproteins
in the cornea, retina, or vitreous. The number of cells in the retinal ganglion cell layer, inner nuclear layer, and outer
nuclear layer decreased remarkably with time in the endothelin-1-treated group. Furthermore, the inner and outer
nuclear layers, as well as the inner and outer plexiform layers, became thinner over time.
Conclusions: Administration of endothelin-1 to the microvasculature of the optic nerve leads to increased
expression of oxyproteins in the optic nerve head and loss of retinal ganglion cells.
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Glaucoma, a leading cause of blindness, is characterized
by progressive retinal ganglion cell loss and excavation
of the optic nerve head. However, the pathophysiologic
mechanisms leading to glaucomatous damage have not
yet been fully elucidated. Elevated intraocular pressure is
considered to be the primary cause of glaucomatous
damage. In addition, clinical studies have suggested that
microcirculatory changes may have a role in glaucoma,
either as the primary abnormality or as a cofactor that
increases susceptibility to pressure damage [1-6]. Fur-
thermore, the relevance of oxidative stress to the patho-
genesis of glaucoma has been demonstrated in cell and
animal studies [7,8]. Elevated pressure causes oxidative* Correspondence: dmkim@snu.or.kr
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reproduction in any medium, provided the orstress in the extracellular matrix of the trabecular mesh-
work, which in turn increases intraocular pressure and
leads to apoptosis of retinal ganglion cells [9-11].
Arterial sclerosis and increased levels of ET-1 can de-
crease blood flow to the optic nerve and trigger oxida-
tive damage. ET-1, a strong vasoconstrictor, increases
vascular resistance, reduces blood flow to the eye, and
induces apoptosis of retinal ganglion cells. ET-1 has also
been shown to bind ETA and ETB receptors in the optic
nerves of rabbits and humans [12,13]. Furthermore, both
glaucoma patients and genetically-modified rats have
been shown to have high intraocular concentrations of
ET-1 [14,15]. Blood flow to the optic nerve is unstably
decreased, and minimal reperfusion is observed after ex-
posure to ET-1 [16]. It is well-known that repeated
chronic oxidative stress caused by reperfusion leads to
the loss of the retinal ganglion cells [17]. Furthermore, a
previous study found that ET-1 is increased and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[18] suggesting that ischemia and oxidative stress are
important factors related to glaucomatous optic nerve
damage.
Increased levels of ET-1 have been known to lead to a
reduction in blood flow in both the choroid and the
optic nerve head [19]. ET-1 constricts vessels both dir-
ectly and indirectly by increasing the sensitivity to other
vasoconstrictive hormones such as norepinephrine, 5-
hydroxytryptamine, and angiotensin-II. An increase in
circulating ET-1 markedly reduces blood flow in the eye
[20]. If the concentration of ET-1 is even higher, it
causes vasospasm [21]. The stimulation of ET receptors
on smooth muscle cells or pericytes increases cytoplas-
mic calcium, both by influx into the cell, as well as by
liberation of calcium from the internal storage [22]. High
levels of ET-1 in the eye cause pro-inflammatory cyto-
kine overproduction and oxidative stress pathway activa-
tion, as well as reduced trophic support and oxygen
delivery to the retina [23].
The purpose of this study was to investigate whether
increased expression of oxyproteins in the optic nerve
head is associated with microcirculatory compromise of
the optic nerve. To this end, we used rabbits in which
endothelin-1 (ET-1; Peptides International, Louisville,
KY) was delivered to the perineural region of the anter-
ior optic nerve by an osmotically-driven minipump
(Alzet Minipumps; Alza Corporation, Palo Alto, CA) as
a model for optic nerve ischemia [24,25]. A reduction of
approximately 38% of the optic nerve blood flow in ET-
1-administered eyes compared with control eyes was
previously demonstrated in this model [26].
Methods
Forty male New Zealand white rabbits weighing 2.5 to
3.5 kg were used for this study. All experiments con-
formed to the Association for Research in Vision and
Ophthalmology statement for the Use of Animals in
Ophthalmic and Vision Research. Rabbits were anesthe-
tized with zoletin and xylazine, after which anterior optic
nerve ischemia was induced as previously described by
Cioffi et al. and Kim et al. [24,25,27,28]. Briefly, ET-1
was delivered to the perineural region of the anterior
optic nerve by osmotically driven minipumps at a con-
trolled and constant flow rate (0.5 μL/h). Minipumps
were implanted in a surgically-created space superior
and nasal to the right eyes. A polyethylene delivery tube
was directed from the minipump through the upper eye-
lid into a surgically-created superior-temporal sub-tenon
channel under the superior rectus muscle. It was fixed
in place using a scleral fixation suture adjacent to the
optic nerve and its vascular supply. A 0.1 μg/day dosage
of ET-1, which was diluted with balanced salt solution
(BSS) was delivered for two (Group II), four (Group III),and eight weeks (Group IV) in ten rabbits, respectively.
As a control, BSS was delivered for two (Group Ia) and
eight weeks (Group Ib) in five rabbits, respectively.
Rabbits were sacrificed and enucleated after two, four,
and eight weeks of ET-1 administration and after two
and eight weeks of BSS administration. After enucle-
ation, oxidative proteins in the cornea, vitreous, retina,
and optic nerve head were measured for each time
period using the OxyBlot protein oxidation detection kit
(Chemicon, Billerica, MA, USA) in triplicate. Protein
oxidation occurs as a result of generation of reactive oxi-
dative products through either direct or indirect path-
ways. The most common in vivo oxidative reaction is
the formation of reactive products with carbonyl func-
tional groups. The detection kit utilizes an immunoblot
that quantifies the level of oxidized proteins formed by
reactions with carbonyls. Briefly, samples were dissolved
in radioimmunoprecipitation assay (RIPA) buffer supple-
mented with 50 mM dithiothreitol to protect against fur-
ther oxidation. The refined protein samples were then
analyzed using the OxyBlot protein oxidation detection
kit. Using this kit, carbonyl groups were converted to
2,4-dinitrophenylhydrazone (DNPH) by reacting with
2,4-dinitrophenylhydrazine. The resulting dinitrophenyl-
derivatized protein samples were blotted onto a membrane
filter, incubated with a peroxidase-antibody conjugate that
binds to the dinitrophenyl section of the protein and goat
anti-rabbit IgG, and visualized with chemiluminescent
reagents. Protein expression was quantified by densitom-
etry. To compare the results of OxyBlot protein oxidation
detection, relative densitometric values of the treated
groups were compared to the control groups. In addition,
retinas from Groups II, III, IV, and Ib were subjected to
H&E and TUNEL staining for histological examination.
TUNEL staining was performed using an ApopTag Perox-
idase In Situ Apoptosis Detection Kit (Millipore, USA).
The sections were treated with proteinase K (DAKO,
USA) and blocked by hydrogen peroxide. Following the
washes, the sections were incubated with an enzyme buf-
fer containing terminal deoxynucleotidyl transferase and
dUTP. The apoptotic cells were detected by DAB sub-
strate chromogen system (DAKO).
Results
Oxyprotein expression was significantly increased in the
optic nerve head in Group II compared with Group Ia
(p < 0.001, Mann Whitney U test, Figure 1). However,
after two weeks, expression had decreased. Furthermore,
there was no difference in the expression of oxyproteins
between Groups IV and Ib. In contrast, oxidative pro-
teins were not expressed in the cornea, vitreous, or ret-
ina (data not shown). The intercellular structures in
each retinal cell layer were destroyed, the intercellular
space loosened, and the cell number in the cell layer
Figure 1 Results of OxyBlot protein detection (A) and relative densitometric values of oxyprotein expression in the optic nerve head
(B, C). Blotting was semi-quantified using densitometry. To compare the results of OxyBlot protein oxidation detection, relative densitometric
values of treated groups were compared to control groups. Endothelin-1 (0.1 μg/day) was delivered to the perineural region of the anterior optic
nerve by osmotically-driven minipumps for two (II), four (III), and eight weeks (IV). As a control, balanced salt solution was delivered for two (Ia)
and eight weeks (Ib). There was a significant increase in the expression of oxyprotein after two weeks of endothelin-1 administration (p < 0.001,
Mann Whitney U test). However, there was no difference between the two groups at eight weeks.
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retinal ganglion cell layer, inner nuclear layer, and outer
nuclear layer decreased notably with time in groups trea-
ted with ET-1 (Figure 2). In addition, the inner and
outer nuclear layers, as well as the inner and outer plexi-
form layers, thinned over time. In Group IV, the outer
limiting membrane exhibited both loosening and widen-
ing. On TUNEL staining, very few apoptotic cells were
observed in the ET-1-treated groups, whereas none were
observed in the control groups (Figure 3).
Discussion
Oxidative damage is the result of oxidative insults due to
the production of reactive oxygen species and reactive
nitrogen species generated by local ischemia. Accord-
ingly, such increases in oxidative protein damage can
affect cellular integrity [29]. In the present study, weevaluated whether the expression of oxyproteins was
increased in the optic nerve head after ET-1-induced
optic nerve ischemia. The number of cells in the retinal
ganglion cell layer and inner and outer nuclear layers, as
well as the thicknesses of the cell layers, decreased over
time. The thickness of the inner and outer plexiform
layer was also decreased. These results suggest that
ischemia-induced oxidative stress can damage both the
retina and optic nerve.
The term ‘oxidative stress’ is used to indicate excessive
increases in the levels of reactive oxygen and nitrogen-
ous compounds compared with normal physiological
intracellular levels [30]. The eye in particular is exposed
to light, radiation, oxygen, and chemicals. In addition,
noxious reactive oxygen/oxygen-derived free radicals are
produced normally during cellular metabolism of oxygen
through processes such as electron hopping and
Figure 2 Retina histological findings (H&E staining, x 200). An endothelin-1 dosage of 0.1 μg/day was delivered for two (II), four (III), and
eight weeks (IV), and balanced salt solution was delivered for eight weeks (Ib) to the perineural region of the anterior optic nerve. Compared to
Group Ib, the number of cells in the retinal ganglion cell layer (long arrow), the inner nuclear layers (short arrow), and the outer nuclear layer
(green arrowhead) were remarkably decreased in Groups II, III, and IV. Vacuoles without a nucleus (empty arrowhead) were found in endothelin-1-
treated groups. In addition, thinning of the inner and outer nuclear layers and the inner and outer plexiform layers was noted. The outer limiting
membrane, composed of the zonula adherens, exhibited loosening and widening (yellow arrowhead).
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dative defense mechanisms have evolved to protect cells
from oxidative damage [31,32]. The oxides produced via
physiological metabolism are eliminated by antioxidants,
and damaged DNA and proteins are repaired. However,
some structural abnormalities resulting from excessive
oxidative stress may be beyond the capacity of physio-
logic recovery mechanisms [33].Figure 3 Retina histological findings (TUNEL staining, x 200). An endo
eight weeks (IV) and balanced salt solution was delivered for eight weeks (
(gray) were observed mainly in the ganglion cell layer (long arrow) and inn
cells were observed in Groups II, III, and IV.Excessive free radicals in a cell can disrupt intracellular
structures, including nucleic acids, lipids, and proteins
[34,35]. Furthermore, proteins are the primary target of
oxygen-derived free radicals [36-39]. An excess in reactive
oxygen species induced by oxidative stress directly triggers
insults in the retina, including mitochondrial dysfunction,
[40] induction of apoptosis, increased neurotoxin produc-
tion, weakening of the neuroprotective functions of glialthelin-1 dosage of 0.1 μg/day was delivered for two (II), four (III), and
Ib) to the perineural region of the anterior optic nerve. Apoptotic cells
er nuclear layer (short arrow) in Group Ib. However, very few apoptotic
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ies. Indeed, oxidative stress in retinal ganglion cells and
retinal proteins may be the cause of optic disc deformities
[10,11].
Quantification of intracellular oxyproteins is necessary
for a comprehensive understanding of oxidative stress.
Measurement of DNPH protein bound carbonyl deriva-
tives is one of the most commonly used strategies to
quantify oxyproteins, and DNPH is quite sensitive with
respect to immunodetection using specific antibodies
[41]. In our study, following two weeks of treatment
with ET-1, the expression of oxyproteins was signifi-
cantly increased compared to the control group. How-
ever, at four and eight weeks, the level of oxyprotein
expression was equal to or slightly decreased compared
to the control group. When a protein undergoes irre-
versible oxidative modifications and cannot be repaired,
it is eliminated through degradation. The mechanisms of
protein elimination are through either proteome-mediated
proteolysis [42] or chaperone-mediated autophagy [43]. In
either case, vulnerable cells damaged by ischemia and oxi-
dative stress may have their damaged proteins eliminated
by these mechanisms, thereby allowing resistant cells to
persist. Thus, equivalent levels of oxyprotein expression at
four and eight weeks suggests the presence of a relative in-
crease in stressful environments as well as expression of
oxidative proteins in the ET-1- administered group com-
pared to the control group.
The results of the present study also demonstrate the
presence of oxidative stress in the control group. Specific-
ally, apoptosis was more apparent in the control group
than in the ET-1-treated group, which may be a reflection
of the effects of natural stress such as light, chemicals, or
radiation. Furthermore, the basal production of reactive
oxygen species, which are regulated by antioxidants, is
part of normal cellular redox homeostasis. Thus, the bal-
ance between native and oxidatively-damaged proteins
depends on the rates of protein biosynthesis, oxidative
modification, and oxidized protein elimination [44].
In our results, there was no expression of oxyproteins
in the retina by oxyblot, yet cell loss was observed in ret-
inal layers. In this study, we analyzed separation of the
optic nerve head from the retinal layer. For this analysis,
we collected optic nerve head tissue, which protrudes
into the globe. The optic nerve head consists mainly of
the surface nerve fiber layer and the prelaminar layer.
Those layers include mainly axons and some deep ret-
inal layers. The structure of the retina containing whole
layer is different from that of the surface retinal layers.
Therefore, if oxyprotein is expressed more in the axons,
the oxyblot result will be different from that of the thin
axons of the existing retinal layers. Since oxyblot is a
quantitative method, a certain amount of oxyprotein is
needed for detection. Therefore, the absence of detectioncan be attributed to a low amount of oxyprotein in the
tissue. To date, there have been no studies regarding
whether oxyprotein can migrate along the axon. In a
previous animal model study, the injection of ET-1 into
the posterior chamber caused a significant constriction
of retinal vessels and impaired retrograde axonal trans-
port by decreasing the number of retinal ganglion cells
[45]. The number of retinal ganglion cells decreased by
44.2% four weeks after the injection of ET-1 into the
posterior chamber. For this reason, apoptosis in retinal
ganglion cells should be rarely observed in the ET-1-
treated group.
Conclusion
The exact mechanisms that lead to damage of the optic
nerve head and retinal ganglion cells in glaucoma are
still unknown, especially in glaucoma without high
intraocular pressure. However, multiple mechanisms and
factors are undoubtedly involved in glaucoma. The
model used in the present study simulates glaucoma
caused by microcirculatory compromise in terms of
optic nerve blood flow reduction. Thus, the current
demonstration of increased expression of oxyprotein in
the optic nerve head in optic nerve ischemia justifies its
use in studies aimed at both understanding and inhibit-
ing the mechanisms associated with retinal ganglion cell
damage.
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